FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2956198239> ?p ?o ?g. }

• W2956198239 endingPage "2210" @default.
• W2956198239 startingPage "2197" @default.
• W2956198239 abstract "Eligibility criteria for hematopoietic stem cell transplantation (HSCT) in acute lymphoblastic leukemia (ALL) vary according to disease characteristics, response to treatment, and type of available donor. As the risk profile of the patient worsens, a wider degree of HLA mismatching is considered acceptable. A total of 138 children and adolescents who underwent HSCT from HLA-identical sibling donors (MSDs) and 210 who underwent HSCT from matched donors (MDs) (median age, 9 years; 68% male) in 10 countries were enrolled in the International-BFM ALL SCT 2007 prospective study to assess the impact of donor type in HSCT for pediatric ALL. The 4-year event-free survival (65 ± 5% vs 61 ± 4%; P = .287), overall survival (72 ± 4% versus 68 ± 4%; P = .235), cumulative incidence of relapse (24 ± 4% versus 25 ± 3%; P = .658) and nonrelapse mortality (10 ± 3% versus 14 ± 3%; P = .212) were not significantly different between MSD and MD graft recipients. The risk of extensive chronic (cGVHD) was lower in MD graft recipients than in MSD graft recipients (hazard ratio [HR], .38; P = .002), and the risks of severe acute GVHD (aGVHD) and cGVHD were higher in peripheral blood stem cell graft recipients than in bone marrow graft recipients (HR, 2.06; P = .026). Compared with the absence of aGVHD, grade I-II aGVHD was associated with a lower risk of graft failure (HR, .63; P = .042) and grade III-IV aGVHD was associated with a higher risk of graft failure (HR, 1.85; P = .020) and nonleukemic death (HR, 8.76; P < .0001), despite a lower risk of relapse (HR, .32; P = .021). Compared with the absence of cGVHD, extensive cGVHD was associated with a higher risk of nonleukemic death (HR, 8.12; P < .0001). Because the outcomes of transplantation from a matched donor were not inferior to those of transplantation from an HLA-identical sibling, eligibility criteria for transplantation might be reviewed in pediatric ALL and possibly in other malignancies as well. Bone marrow should be the preferred stem cell source, and the addition of MTX should be considered in MSD graft recipients." @default.
• W2956198239 created "2019-07-23" @default.
• W2956198239 creator A5000105491 @default.
• W2956198239 creator A5005040866 @default.
• W2956198239 creator A5015116246 @default.
• W2956198239 creator A5019321682 @default.
• W2956198239 creator A5019611890 @default.
• W2956198239 creator A5020616500 @default.
• W2956198239 creator A5043164298 @default.
• W2956198239 creator A5045304343 @default.
• W2956198239 creator A5054904756 @default.
• W2956198239 creator A5057471061 @default.
• W2956198239 creator A5059323640 @default.
• W2956198239 creator A5064396176 @default.
• W2956198239 creator A5075403858 @default.
• W2956198239 creator A5076801164 @default.
• W2956198239 creator A5078858949 @default.
• W2956198239 creator A5082616655 @default.
• W2956198239 date "2019-11-01" @default.
• W2956198239 modified "2023-10-12" @default.
• W2956198239 title "Transplantation in Children and Adolescents with Acute Lymphoblastic Leukemia from a Matched Donor versus an HLA-Identical Sibling: Is the Outcome Comparable? Results from the International BFM ALL SCT 2007 Study" @default.
• W2956198239 cites W111189903 @default.
• W2956198239 cites W1481061448 @default.
• W2956198239 cites W1529256508 @default.
• W2956198239 cites W1697843215 @default.
• W2956198239 cites W1976767488 @default.
• W2956198239 cites W2007364929 @default.
• W2956198239 cites W2008869193 @default.
• W2956198239 cites W2009105008 @default.
• W2956198239 cites W2021312489 @default.
• W2956198239 cites W2028539310 @default.
• W2956198239 cites W2031803874 @default.
• W2956198239 cites W2037297987 @default.
• W2956198239 cites W2038981426 @default.
• W2956198239 cites W2039715386 @default.
• W2956198239 cites W2041055738 @default.
• W2956198239 cites W2050796386 @default.
• W2956198239 cites W2059821730 @default.
• W2956198239 cites W2064396597 @default.
• W2956198239 cites W2070962119 @default.
• W2956198239 cites W2073140442 @default.
• W2956198239 cites W2079334334 @default.
• W2956198239 cites W2086856829 @default.
• W2956198239 cites W2109285747 @default.
• W2956198239 cites W2112400170 @default.
• W2956198239 cites W2115896858 @default.
• W2956198239 cites W2126021331 @default.
• W2956198239 cites W2133104010 @default.
• W2956198239 cites W2134118606 @default.
• W2956198239 cites W2134638406 @default.
• W2956198239 cites W2139813696 @default.
• W2956198239 cites W2141870697 @default.
• W2956198239 cites W2148631711 @default.
• W2956198239 cites W2157460080 @default.
• W2956198239 cites W2167854578 @default.
• W2956198239 cites W2233354089 @default.
• W2956198239 cites W2605507331 @default.
• W2956198239 cites W2618073389 @default.
• W2956198239 cites W2739677176 @default.
• W2956198239 cites W2803094727 @default.
• W2956198239 cites W2938850398 @default.
• W2956198239 doi "https://doi.org/10.1016/j.bbmt.2019.07.011" @default.
• W2956198239 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31319153" @default.
• W2956198239 hasPublicationYear "2019" @default.
• W2956198239 type Work @default.
• W2956198239 sameAs 2956198239 @default.
• W2956198239 citedByCount "27" @default.
• W2956198239 countsByYear W29561982392020 @default.
• W2956198239 countsByYear W29561982392021 @default.
• W2956198239 countsByYear W29561982392022 @default.
• W2956198239 countsByYear W29561982392023 @default.
• W2956198239 crossrefType "journal-article" @default.
• W2956198239 hasAuthorship W2956198239A5000105491 @default.
• W2956198239 hasAuthorship W2956198239A5005040866 @default.
• W2956198239 hasAuthorship W2956198239A5015116246 @default.
• W2956198239 hasAuthorship W2956198239A5019321682 @default.
• W2956198239 hasAuthorship W2956198239A5019611890 @default.
• W2956198239 hasAuthorship W2956198239A5020616500 @default.
• W2956198239 hasAuthorship W2956198239A5043164298 @default.
• W2956198239 hasAuthorship W2956198239A5045304343 @default.
• W2956198239 hasAuthorship W2956198239A5054904756 @default.
• W2956198239 hasAuthorship W2956198239A5057471061 @default.
• W2956198239 hasAuthorship W2956198239A5059323640 @default.
• W2956198239 hasAuthorship W2956198239A5064396176 @default.
• W2956198239 hasAuthorship W2956198239A5075403858 @default.
• W2956198239 hasAuthorship W2956198239A5076801164 @default.
• W2956198239 hasAuthorship W2956198239A5078858949 @default.
• W2956198239 hasAuthorship W2956198239A5082616655 @default.
• W2956198239 hasBestOaLocation W29561982391 @default.
• W2956198239 hasConcept C120665830 @default.
• W2956198239 hasConcept C121332964 @default.
• W2956198239 hasConcept C126322002 @default.
• W2956198239 hasConcept C138496976 @default.
• W2956198239 hasConcept C141071460 @default.
• W2956198239 hasConcept C147483822 @default.
• W2956198239 hasConcept C15744967 @default.
• W2956198239 hasConcept C188280979 @default.
• W2956198239 hasConcept C203014093 @default.

• next